Kelyniam Global
OTC: KLYGCanton, US · Nevada corporation
Find your way into Kelyniam Global
65 people in our graph share verified history with the Kelyniam Global team — schools, employers, funds. One of them is your warm intro.
Kelyniam manufactures custom cranial and craniofacial implants for surgical specialists and hospitals, featuring patented Integrated Fixation System tabs and 24-48 hour production turnaround using 3D printing technology. The company also distributes complementary bone substitute products and operates as a medical device manufacturer focused on the osteointegrative implant market.
Founders & leadership


Board
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2024
▶$250KraisedDec 2024 · 4 investors · Other Health CareRule 506(b)
- Lisette GrunwellDirector
- Terrance KurtenbachExecutive Officer, Director
- Jonathan ThielDirector
- Desiree WebbDirector
- Ross BjellaExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Nov 2024
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with Kelyniam Global for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Kelyniam Global do?
- Kelyniam manufactures custom cranial and craniofacial implants for surgical specialists and hospitals, featuring patented Integrated Fixation System tabs and 24-48 hour production turnaround using 3D printing technology. The company also distributes complementary bone substitute products and operates as a medical device manufacturer focused on the osteointegrative implant market.
- How much funding has Kelyniam Global raised?
- Kelyniam Global has disclosed $250K raised across 1 round.
- Where is Kelyniam Global headquartered?
- Kelyniam Global is headquartered in Canton, US.



